Medical Science Liaison, stroke ​/cardiorenal - Ontario

At Bayer we’re visionaries, driven to solve the world’s toughest challenges and striving for a world where ,Health for all, Hunger for none’ is no longer a dream, but a real possibility. We’re doing it with energy, curiosity and sheer dedication, always learning from unique perspectives of those around us, expanding our thinking, growing our capabilities and redefining ‘impossible’. There are so many reasons to join us.

If you’re hungry to build a varied and meaningful career in a community of brilliant and diverse minds to make a real difference, there’s only one choice.

The Medical Science Liaison (MSL) acts as a primary (but not exclusive) point of contact (PPOC) between Bayer and Thought Leaders (TLs) and acts as the scientific expert between Bayer and the medical community to facilitate education and evidence generation. The MSL - stroke / cardiorenal shall act as a scientific expert and liaison between Bayer and the medical community through the dissemination and education of scientific data and material (including but limited to clinical research, real world evidence and health economic outcomes research).

The MSL establishes long‑term scientific and strategic relationships with Thought Leaders (TLs) (key, influential health care professionals/ scientists/ stakeholders who are involved in research activities, academic education, clinical guidelines and/or act as experts for reimbursement bodies) as well as with related major medical associations and academic centres. The MSL facilitates TL involvement in international, national, and regional initiatives, including advisory boards, learning programs, Continuing Medical Education (CME), research and publications.

The MSL also serves as an important cross‑functional internal partner to Bayer by sharing relevant information/ insights from TLs, developing and delivering product and therapeutic area training, and contributing strategic input to market access and research activities.

• Exchange and dissemination of scientific educational, and research related information:
  As the PPOC for assigned TLs, the MSL plans, partners and engages with TLs as a subject matter expert both proactively and reactively via various innovative, omnichannel TL engagement formats (aligned to customer preferences) to disseminate, clarify and educate on scientific data, study protocols, conference abstracts, publications and clinical guidelines. The MSL also collaborates with other field roles (ex. commercial field roles, market access, etc) to ensure the scientific needs of all stakeholders are addressed, as needed.
  
  (Both proactive discussions on-label, and reactive discussions for unsolicited off‑label questions in alignment with local regulations)
• Act as primary point of contact (PPOC) for key TLs, responsible for fostering strong partnerships and play the role of ‘trusted advisor’ and ‘conductor’ to shape and synergize to reach win‑win outcomes.
• TL identification, profiling, segmentation and engagement planning:
  Responsible for executing medical strategy by translating the local medical plan into implementable TL engagement plans in collaboration with cross‑functional team and identify synergies with interests of Bayer and the medical community.
• Responsible for generating TL insights on current clinical practice, beliefs and unmet medical needs, document and communicate them to cross‑functional partners to inform agile planning cycles
• Responsible for keeping abreast with latest scientific research on therapeutic area and developing strong understanding of Bayer’s market strategies and the healthcare landscape (including healthcare systems, competition, regulations, etc) so as to anticipate internal and external stakeholder needs and shape plans accordingly
• Coordinate and organize scientific learning activities within the therapeutic area, working with TLs and other Bayer partners, as needed
• Organize and lead regional consultant meetings related to current and evolving clinical practice, ongoing research, pipeline assets and future indications to gather insights and shape go‑to‑market strategies.
• C…